Pharmacologic treatment of kidney stone disease.
| Publicado en: | Urologic Clinics of North America Vol. 40; no. 1; pp. 21 - 31 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
W B Saunders
2013 Feb
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108088194&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108088194 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00940143 1VA jtl: Urologic Clinics of North America issn: 00940143 maglogo: N pubinfo: dt: 2013 Feb vid: 40 iid: 1 pid: 1351 pub: W B Saunders place: Philadelphia, Pennsylvania artinfo: ui: 108088194 2011799917 10.1016/j.ucl.2012.09.013 NLM23177632 108088194 ppf: 21 ppct: 10 formats: tig: atl: Pharmacologic treatment of kidney stone disease. aug: au: Eisner BH Goldfarb DS Pareek G affil: Department of Urology, GRB 1102, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: beisner@partners.org. sug: subj: Allopurinol Therapeutic Use Kidney Calculi Drug Therapy Sulfur Compounds Therapeutic Use Enzyme Inhibitors Therapeutic Use Treatment Outcomes Urease Antagonists and Inhibitors pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|